• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BLT
Click for more information
5.77% 5.5¢

BENITEC BIOPHARMA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BLT OPMD ORPHAN DISEASE PROGRAM ADVANCEMENTPRICE SENSITIVE08/08/17
BLT Appendix 4C - quarterlyPRICE SENSITIVE27/07/17
BLT Appendix 3B18/07/17
BLT RESEARCH & DEVELOPMENT GRANT RECEIVEDPRICE SENSITIVE09/06/17
BLT SEC SHELF REGISTRATIONPRICE SENSITIVE02/06/17
BLT QUARTERLY CORPORATE CALL TRANSCRIPT31/05/17
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2017PRICE SENSITIVE30/05/17
BLT QUARTERLY CORPORATE UPDATE CALL23/05/17
BLT Appendix 4C - quarterlyPRICE SENSITIVE27/04/17
BLT Appendix 3B11/04/17
BLT OPMD KEY DATA PUBLISHED IN NATUREPRICE SENSITIVE03/04/17
BLT RESEARCH & DEVELOPMENT GRANT RECEIVEDPRICE SENSITIVE24/03/17
BLT QUARTERLY CORPORATE CALL TRANSCRIPT23/03/17
BLT QUARTERLY CORPORATE UPDATE CALL17/03/17
BLT Change in substantial holding15/03/17
BLT s708 CLEANSING STATEMENT13/03/17
BLT Appendix 3B13/03/17
BLT CLOSING OF NANT SECOND TRANCHE PLACEMENTPRICE SENSITIVE13/03/17
BLT AGREEMENT ON NANT SECOND TRANCHE PLACEMENTPRICE SENSITIVE08/03/17
BLT REVISED SHARE TRADING POLICY01/03/17
BLT Half Yearly Report and AccountsPRICE SENSITIVE22/02/17
BLT HBV DATA PRESENTATION AT APASL SHANGHAI17/02/17
BLT Appendix 3B07/02/17
BLT AMENDMENT TO INVESTMENT DATES IN NANT AGREEMENT03/02/17
BLT UPDATE ON OCULAR PROGRAM AND PRESENTATIONPRICE SENSITIVE02/02/17
BLT Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
BLT ONCOLOGY PROGRAM INITIATED WITH NANTPRICE SENSITIVE30/01/17
BLT Ceasing to be a substantial holder19/01/17
BLT BENITEC ANNOUNCES EU ODD FOR BB301PRICE SENSITIVE17/01/17
BLT BENITEC TO PRESENT AT BIOTECH SHOWCASE06/01/17
BLT Cancer program in-licensed from NantPRICE SENSITIVE23/12/16
BLT MARKET UPDATEPRICE SENSITIVE22/12/16
BLT Benitec announces pivotal HBV in vivo dataPRICE SENSITIVE21/12/16
BLT AGM PROXY VOTES14/12/16
BLT AGM CHAIRMAN ADDRESS14/12/16
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT23/11/16
BLT INTERIM REPORT THREE MONTHS TO 30 SEPTEMBER 201622/11/16
BLT QUARTERLY CORPORATE UPDATE CALL18/11/16
BLT Appendix 3B17/11/16
BLT Annual Report to shareholders14/11/16
BLT Notice of Annual General Meeting/Proxy Form14/11/16
BLT CORPORATE PRESENTATION11/11/16
BLT Initial Director's Interest Notice-BLT.AX 01/11/16
BLT DIRECTOR APPOINTMENT-BLT.AX 01/11/16
BLT SEC FORM 20F-BLT.AX 01/11/16
BLT Appendix 4C - quarterly-BLT.AX PRICE SENSITIVE28/10/16
BLT Ceasing to be a substantial holder-BLT.AX 27/10/16
BLT Becoming a substantial holder-BLT.AX 25/10/16
BLT Cleansing Notice Re Nant Capital-BLT.AX 24/10/16
BLT Appendix 3B Nant Capital Placement-BLT.AX 24/10/16
BLT Benitec announces date of AGM-BLT.AX 24/10/16
BLT Strateigc engagement with NantVentures-BLT.AX PRICE SENSITIVE24/10/16
BLT CHANGE IN REGISTERED OFFICE-BLT.AX 20/10/16
BLT BENITEC PRESENTS AT ESGCT-BLT.AX 20/10/16
BLT CHANGE IN COMPANY SECRETARY-BLT.AX 18/10/16
BLT Response to ASX Appendix 3X and 3Y Query-BLT.AX 12/10/16
BLT Change of Director's Interest Notice-BLT.AX 07/10/16
BLT Change of Director's Interest Notice-BLT.AX 07/10/16
BLT Initial Director's Interest Notice-BLT.AX 07/10/16
BLT Appendix 3B-BLT.AX 07/10/16
BLT Final Director's Interest Notice-BLT.AX 07/10/16
BLT BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX PRICE SENSITIVE16/09/16
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT-BLT.AX 31/08/16
BLT Appendix 4G and Corporate Governance-BLT.AX 30/08/16
BLT Preliminary Final Report-BLT.AX PRICE SENSITIVE30/08/16
BLT QUARTERLY CORPORATE UPDATE CONFERENCE CALL-BLT.AX 23/08/16
BLT Appendix 3B-BLT.AX 16/08/16
BLT DIRECTOR APPOINTMENT AND RESIGNATION-BLT.AX 16/08/16
BLT RESTRUCTURING OF SENIOR EXECUTIVE TEAM-BLT.AX PRICE SENSITIVE10/08/16
BLT Appendix 4C - quarterly-BLT.AX PRICE SENSITIVE28/07/16
BLT Response to ASX price query-BLT.AX PRICE SENSITIVE20/07/16
BLT FEDERAL R&D GRANT RECEIVED-BLT.AX PRICE SENSITIVE16/06/16
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT-BLT.AX 25/05/16
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2016-BLT.AX 24/05/16
BLT QUARTERLY CORPORATE UPDATE CONFERENCE CALL-BLT.AX 17/05/16
BLT Appendix 4C - quarterly-BLT.AX PRICE SENSITIVE29/04/16
BLT BENITEC TO PRESENT AT ASGCT-BLT.AX 21/04/16
BLT Change in substantial holding-BLT.AX 07/04/16
BLT BENITEC PRESENTS AT CANARY BIOTECH INVESTOR FORUM17/03/16
BLT POSITIVE HBV IN VIVO DATAPRICE SENSITIVE08/03/16
BLT BUSINESS UPDATE CONFERENCE CALL TRANSCRIPT01/03/16
BLT Half Yearly Report and AccountsPRICE SENSITIVE26/02/16
BLT UPDATE ON HCV CLINICAL TRIALPRICE SENSITIVE26/02/16
BLT Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
BLT Change in substantial holding22/01/16
BLT BENITEC PRESENTS AT BIOTECH SHOWCASE CONFERENCE12/01/16
BLT Final Director's Interest Notice24/12/15
BLT Appendix 3B24/12/15
BLT Change of Director's Interest Notice24/12/15
BLT Change of Director's Interest Notice24/12/15
BLT Change of Director's Interest Notice24/12/15
BLT Change of Director's Interest Notice24/12/15
BLT Change of Director's Interest Notice24/12/15
BLT Appendix 3B24/12/15
BLT BENITEC TO HOST CONFERENCE CALL11/12/15
BLT BENITEC CFO APPOINTED INTERIM CEOPRICE SENSITIVE09/12/15
BLT HEP B PRECLINICAL RESULTSPRICE SENSITIVE07/12/15
BLT Results of Meeting12/11/15
BLT Chairman's Address to Shareholders12/11/15
BLT Appendix 4C - quarterlyPRICE SENSITIVE30/10/15
BLT OPMD ORPHAN DISEASE PROGRAM ADVANCEMENT
08/08/17PRICE SENSITIVE
BLT Appendix 4C - quarterly
27/07/17PRICE SENSITIVE
BLT Appendix 3B
18/07/17
BLT RESEARCH & DEVELOPMENT GRANT RECEIVED
09/06/17PRICE SENSITIVE
BLT SEC SHELF REGISTRATION
02/06/17PRICE SENSITIVE
BLT QUARTERLY CORPORATE CALL TRANSCRIPT
31/05/17
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2017
30/05/17PRICE SENSITIVE
BLT QUARTERLY CORPORATE UPDATE CALL
23/05/17
BLT Appendix 4C - quarterly
27/04/17PRICE SENSITIVE
BLT Appendix 3B
11/04/17
BLT OPMD KEY DATA PUBLISHED IN NATURE
03/04/17PRICE SENSITIVE
BLT RESEARCH & DEVELOPMENT GRANT RECEIVED
24/03/17PRICE SENSITIVE
BLT QUARTERLY CORPORATE CALL TRANSCRIPT
23/03/17
BLT QUARTERLY CORPORATE UPDATE CALL
17/03/17
BLT Change in substantial holding
15/03/17
BLT s708 CLEANSING STATEMENT
13/03/17
BLT Appendix 3B
13/03/17
BLT CLOSING OF NANT SECOND TRANCHE PLACEMENT
13/03/17PRICE SENSITIVE
BLT AGREEMENT ON NANT SECOND TRANCHE PLACEMENT
08/03/17PRICE SENSITIVE
BLT REVISED SHARE TRADING POLICY
01/03/17
BLT Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE
BLT HBV DATA PRESENTATION AT APASL SHANGHAI
17/02/17
BLT Appendix 3B
07/02/17
BLT AMENDMENT TO INVESTMENT DATES IN NANT AGREEMENT
03/02/17
BLT UPDATE ON OCULAR PROGRAM AND PRESENTATION
02/02/17PRICE SENSITIVE
BLT Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
BLT ONCOLOGY PROGRAM INITIATED WITH NANT
30/01/17PRICE SENSITIVE
BLT Ceasing to be a substantial holder
19/01/17
BLT BENITEC ANNOUNCES EU ODD FOR BB301
17/01/17PRICE SENSITIVE
BLT BENITEC TO PRESENT AT BIOTECH SHOWCASE
06/01/17
BLT Cancer program in-licensed from Nant
23/12/16PRICE SENSITIVE
BLT MARKET UPDATE
22/12/16PRICE SENSITIVE
BLT Benitec announces pivotal HBV in vivo data
21/12/16PRICE SENSITIVE
BLT AGM PROXY VOTES
14/12/16
BLT AGM CHAIRMAN ADDRESS
14/12/16
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT
23/11/16
BLT INTERIM REPORT THREE MONTHS TO 30 SEPTEMBER 2016
22/11/16
BLT QUARTERLY CORPORATE UPDATE CALL
18/11/16
BLT Appendix 3B
17/11/16
BLT Annual Report to shareholders
14/11/16
BLT Notice of Annual General Meeting/Proxy Form
14/11/16
BLT CORPORATE PRESENTATION
11/11/16
BLT Initial Director's Interest Notice-BLT.AX
01/11/16
BLT DIRECTOR APPOINTMENT-BLT.AX
01/11/16
BLT SEC FORM 20F-BLT.AX
01/11/16
BLT Appendix 4C - quarterly-BLT.AX
28/10/16PRICE SENSITIVE
BLT Ceasing to be a substantial holder-BLT.AX
27/10/16
BLT Becoming a substantial holder-BLT.AX
25/10/16
BLT Cleansing Notice Re Nant Capital-BLT.AX
24/10/16
BLT Appendix 3B Nant Capital Placement-BLT.AX
24/10/16
BLT Benitec announces date of AGM-BLT.AX
24/10/16
BLT Strateigc engagement with NantVentures-BLT.AX
24/10/16PRICE SENSITIVE
BLT CHANGE IN REGISTERED OFFICE-BLT.AX
20/10/16
BLT BENITEC PRESENTS AT ESGCT-BLT.AX
20/10/16
BLT CHANGE IN COMPANY SECRETARY-BLT.AX
18/10/16
BLT Response to ASX Appendix 3X and 3Y Query-BLT.AX
12/10/16
BLT Change of Director's Interest Notice-BLT.AX
07/10/16
BLT Change of Director's Interest Notice-BLT.AX
07/10/16
BLT Initial Director's Interest Notice-BLT.AX
07/10/16
BLT Appendix 3B-BLT.AX
07/10/16
BLT Final Director's Interest Notice-BLT.AX
07/10/16
BLT BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX
16/09/16PRICE SENSITIVE
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT-BLT.AX
31/08/16
BLT Appendix 4G and Corporate Governance-BLT.AX
30/08/16
BLT Preliminary Final Report-BLT.AX
30/08/16PRICE SENSITIVE
BLT QUARTERLY CORPORATE UPDATE CONFERENCE CALL-BLT.AX
23/08/16
BLT Appendix 3B-BLT.AX
16/08/16
BLT DIRECTOR APPOINTMENT AND RESIGNATION-BLT.AX
16/08/16
BLT RESTRUCTURING OF SENIOR EXECUTIVE TEAM-BLT.AX
10/08/16PRICE SENSITIVE
BLT Appendix 4C - quarterly-BLT.AX
28/07/16PRICE SENSITIVE
BLT Response to ASX price query-BLT.AX
20/07/16PRICE SENSITIVE
BLT FEDERAL R&D GRANT RECEIVED-BLT.AX
16/06/16PRICE SENSITIVE
BLT QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT-BLT.AX
25/05/16
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2016-BLT.AX
24/05/16
BLT QUARTERLY CORPORATE UPDATE CONFERENCE CALL-BLT.AX
17/05/16
BLT Appendix 4C - quarterly-BLT.AX
29/04/16PRICE SENSITIVE
BLT BENITEC TO PRESENT AT ASGCT-BLT.AX
21/04/16
BLT Change in substantial holding-BLT.AX
07/04/16
BLT BENITEC PRESENTS AT CANARY BIOTECH INVESTOR FORUM
17/03/16
BLT POSITIVE HBV IN VIVO DATA
08/03/16PRICE SENSITIVE
BLT BUSINESS UPDATE CONFERENCE CALL TRANSCRIPT
01/03/16
BLT Half Yearly Report and Accounts
26/02/16PRICE SENSITIVE
BLT UPDATE ON HCV CLINICAL TRIAL
26/02/16PRICE SENSITIVE
BLT Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
BLT Change in substantial holding
22/01/16
BLT BENITEC PRESENTS AT BIOTECH SHOWCASE CONFERENCE
12/01/16
BLT Final Director's Interest Notice
24/12/15
BLT Appendix 3B
24/12/15
BLT Change of Director's Interest Notice
24/12/15
BLT Change of Director's Interest Notice
24/12/15
BLT Change of Director's Interest Notice
24/12/15
BLT Change of Director's Interest Notice
24/12/15
BLT Change of Director's Interest Notice
24/12/15
BLT Appendix 3B
24/12/15
BLT BENITEC TO HOST CONFERENCE CALL
11/12/15
BLT BENITEC CFO APPOINTED INTERIM CEO
09/12/15PRICE SENSITIVE
BLT HEP B PRECLINICAL RESULTS
07/12/15PRICE SENSITIVE
BLT Results of Meeting
12/11/15
BLT Chairman's Address to Shareholders
12/11/15
BLT Appendix 4C - quarterly
30/10/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.